C. Lewden, T. May, E. Rosenthal, C. Burty, F. Bonnet et al., Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The ???Mortalit?? 2000 and 2005??? Surveys (ANRS EN19 and Mortavic), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.48, issue.5, pp.590-598, 2000.
DOI : 10.1097/QAI.0b013e31817efb54

D. Thomas, HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS), Lancet, vol.360, pp.1921-1926, 2002.

G. Nikolopoulos, D. Paraskevis, E. Hatzitheodorou, Z. Moschidis, V. Sypsa et al., Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV???Infected Individuals: A Cohort Study and Meta???Analysis, Clinical Infectious Diseases, vol.48, issue.12, pp.1763-1771736, 2009.
DOI : 10.1086/599110

U. Iloeje, H. Yang, J. Su, C. Jen, S. You et al., Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load, Gastroenterology, vol.130, issue.3, pp.678-686, 2006.
DOI : 10.1053/j.gastro.2005.11.016

W. Lee, Hepatitis B Virus Infection, New England Journal of Medicine, vol.337, issue.24, pp.1733-1745, 1997.
DOI : 10.1056/NEJM199712113372406
URL : https://hal.archives-ouvertes.fr/hal-01260424

D. Ganem and A. Prince, Hepatitis B Virus Infection ??? Natural History and Clinical Consequences, New England Journal of Medicine, vol.350, issue.11, pp.1118-1129, 2004.
DOI : 10.1056/NEJMra031087

A. Kay and F. Zoulim, Hepatitis B virus genetic variability and evolution, Virus Research, vol.127, issue.2, pp.164-176, 2007.
DOI : 10.1016/j.virusres.2007.02.021
URL : https://hal.archives-ouvertes.fr/inserm-00133137

C. Olinger, P. Jutavijittum, J. Hübschen, A. Yousukh, B. Samountry et al., Possible New Hepatitis B Virus Genotype, Southeast Asia, Emerging Infectious Diseases, vol.14, issue.11, pp.1777-1780, 2008.
DOI : 10.3201/eid1411.080437

K. Tatematsu, Y. Tanaka, F. Kurbanov, F. Sugauchi, S. Mano et al., A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J, Journal of Virology, vol.83, issue.20, pp.10538-10547, 2009.
DOI : 10.1128/JVI.00462-09

K. Lacombe, V. Massari, P. Girard, L. Serfaty, J. Gozlan et al., Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV, AIDS, vol.20, issue.3, pp.419-427, 2006.
DOI : 10.1097/01.aids.0000200537.86984.0e

G. Matthews, A. Bartholomeusz, S. Locarnini, A. Ayres, J. Sasaduesz et al., Characteristics of drug resistant

M. Romero, P. Barreiro, J. Garcia-samaniego, V. Soriano, M. Peters et al., Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients, J Acquir Immune Defic Syndr, vol.44, issue.14, pp.557-561, 2007.

B. Polsky, Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127, Hepatology, vol.44, pp.1110-1116, 2006.

G. Dore, A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand, Hepatology, vol.48, pp.1062-1069, 2008.

H. Thomas, The hepatitis B virus and the host response, Journal of Hepatology, vol.11, pp.83-89, 1990.
DOI : 10.1016/0168-8278(90)90170-V

T. Baumert, S. Rogers, K. Hasegawa, and T. Liang, Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication., Journal of Clinical Investigation, vol.98, issue.10, pp.2268-2276, 1996.
DOI : 10.1172/JCI119037

&. Tong, S. Jammeh, S. Tavner, F. Watson, R. Thomas et al., Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants Effect of basal core promoter and pre-core mutations on hepatitis B virus replication, J Virol J Gen Virol, vol.77, issue.89, pp.6601-6612901, 2003.

K. Hasegawa, J. Huang, S. Rogers, H. Blum, T. Liang et al., Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness, J Virol N Engl J Med J Gen Virol, vol.68, issue.81, pp.1651-16591705, 1991.

M. Mizokami, Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F), J. Virol, vol.76, pp.6131-6137, 2002.

Y. Benhamou, M. Bochet, V. Thibault, D. Martino, V. Caumes et al., Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients, Hepatology, vol.29, issue.5, pp.1302-1306, 1999.
DOI : 10.1002/hep.510300525

M. Correa, V. Soriano, P. Phiri, A. Hall, H. Brett-smith et al., Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy Telbivudine has activity against HIV-1, AIDS AIDS, vol.22, issue.1011, pp.1779-1787546, 2008.

C. Avila, S. Karwowska, C. Lai, T. Evans, V. Thibault et al., Telbivudine Has No in vitro Activity against Laboratory and Clinical HIV-1, including 5 Clades and Drug-resistant Clinical Isolates. CROI Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1, Journal of Hepatology, vol.44, pp.62-67, 2006.

K. Lacombe, A. Ollivet, J. Gozlan, S. Durantel, N. Tran et al., A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV???hepatitis B virus-co-infected patient, AIDS, vol.20, issue.17, pp.2229-2231, 2006.
DOI : 10.1097/01.aids.0000252061.35422.84

S. Amini-bavil-olyaee, U. Herbers, J. Sheldon, T. Luedde, C. Trautwein et al., The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains, Hepatology, vol.3, issue.4, pp.1158-1165, 2009.
DOI : 10.1002/hep.22790

J. Audsley, N. Arrifin, L. Yuen, A. Ayres, S. Crowe et al., Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations, HIV Medicine, vol.10, issue.4, pp.229-235, 2009.
DOI : 10.1111/j.1468-1293.2008.00675.x

K. Lacombe, A. Boyd, F. Lavocat, J. Gozlan, P. Miailhes et al., Treament-induced and vaccine escape HBV mutants in HIV-HBV co-infected patients: a longitudinal analysis Abstract 218. 33 Tenofovir (TDF) is effective in lamivudine (LAM)-resistant chronic hepatitis B patients who harbor rtA194T as baseline Abstract 399 Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital Vaccine-induced escape mutant of hepatitis B virus The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen, Hepatology J Med Virol Lancet J Clin Microbiol, vol.34, issue.45, pp.254-263406, 1990.

J. Torresi, The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus, Journal of Clinical Virology, vol.25, issue.2, pp.97-106, 2002.
DOI : 10.1016/S1386-6532(02)00049-5

K. Krawczynski, Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model, Hepatology, vol.49, issue.40, pp.1483-1491, 2009.

V. Svicher, F. Forbici, C. Alteri, F. Ceccherini-silberstein, E. Boumis et al., HIV-driven Immunosuppression Regulates HBV Evolution in HBV/HIV-co-infected Patients. CROI Montréal, pp.8-11